Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)

ClinicalTrials.gov ID: NCT03566823

Public ClinicalTrials.gov record NCT03566823. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 12:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of Ontamalimab in inducing clinical remission and endoscopic response in participants with moderate to severe Crohn's Disease.

Study identification

NCT ID
NCT03566823
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
34 participants

Conditions and interventions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
16 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 17, 2018 (Actual)
Primary completion
Aug 18, 2020 (Actual)
Completion
Aug 18, 2020 (Actual)
Last update posted
May 11, 2021

2018 – 2020

United States locations

U.S. sites
48
U.S. states
17
U.S. cities
44
Facility City State ZIP Site status
Arizona Digestive Health Mesa - East Mesa Arizona 85206 —
Elite Clinical Studies - Phoenix - Clinedge - PPDS Phoenix Arizona 85018 —
Advanced Research Center Anaheim California 92805 —
Kindred Medical Institute for Clinical Trials, LLC Corona California 92879 —
Alliance Clinical Research-(Vestavia Hills) Poway California 92064 —
Care Access Research, San Pablo San Pablo California 94806 —
Renaissance Research Medical Group, INC Cape Coral Florida 33991 —
Gastro Florida Clearwater Florida 33756 —
Alliance Medical Research LLC Coral Springs Florida 33071 —
SIH Research Kissimmee Florida 34741 —
Hi Tech and Global Research, LLc Miami Florida 33135 —
Sanchez Clinical Research, Inc Miami Florida 33157 —
Crystal Biomedical Research Miami Lakes Florida 33065 —
Pharma Research International Inc Naples Florida 34110 —
Bayside Clinical Research - New Port Richey New Port Richey Florida 34655 —
Accel Research Sites - St. Petersburg - ERN - PPDS Pinellas Park Florida 33781 —
DBC Research Tamarac Florida 33321 —
Infinite Clinical Trials Atlanta Georgia 30349 —
Atlanta Center For Gastroenterology PC Decatur Georgia 30033 —
Atlanta Gastroenterology Specialists, PC Suwanee Georgia 30024 —
Loretto Hospital Chicago Illinois 60644 —
IL Gastroenterology Group Gurnee Illinois 60031 —
Cotton O'Neil Clinical Research Center Topeka Kansas 66606 —
Gastroenterology Associates of Hazard Hazard Kentucky 41701 —
CroNOLA, LLC. Houma Louisiana 70360 —
DelRicht Clinical Research, LLC - ClinEdge - PPDS New Orleans Louisiana 70115 —
Commonwealth Clinical Studies LLC Brockton Massachusetts 02302 —
Winchester Gastroenterology Associates Winchester Massachusetts 22601 —
UMass Memorial Medical Center Worcester Massachusetts 01655 —
University of Michigan Ann Arbor Michigan 48109 —
Clinical Research Institute of Michigan Chesterfield Michigan 48047 —
National Clinical, LLC Hamtramck Michigan 48212 —
Gastroenterology Associates of Western Michigan, PLC Wyoming Michigan 49519 —
Mayo Clinic Health System - PPDS Duluth Minnesota 55805 —
Minnesota Gastroenterology PA Plymouth Minnesota 55446 —
Washington University in St. Louis St Louis Missouri 63110 —
Advanced Biomedical Research of America Las Vegas Nevada 89123 —
Encompass Care North Las Vegas Nevada 89086 —
NYU Langone Long Island Clinical Research Associates Great Neck New York 11021 —
Southtowns Gastroenterology, PLLC Orchard Park New York 14127 —
Penn State Hershey Medical Group State College Pennsylvania 16803 —
Digestive Health Associates of Texas, P.A.dba DHAT Research Institute Garland Texas 75044 —
Precision Research Institute, LLC Houston Texas 77039 —
Biopharma Informatic Inc. Houston Texas 77043 —
Southwest Clinical Trials Houston Texas 77074 —
BI Research Center Houston Texas 77084 —
Southern Star Research Institute LLC San Antonio Texas 78229 —
Mid Atlantic Health Specialists Galax Virginia 24333 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 97 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03566823, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2021 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03566823 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →